TAZEPROFEN

Details

Stereochemistry	RACEMIC
Molecular Formula	C16H13NO2S
Molecular Weight	283.345
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(C(O)=O)C1=CC=C2N=C(SC2=C1)C3=CC=CC=C3

InChI

InChIKey=DPRKTNKWAXPYNW-UHFFFAOYSA-N

InChI=1S/C16H13NO2S/c1-10(16(18)19)12-7-8-13-14(9-12)20-15(17-13)11-5-3-2-4-6-11/h2-10H,1H3,(H,18,19)

HIDE SMILES / InChI

Molecular Formula	C16H13NO2S
Molecular Weight	283.345
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2889550 | https://www.ncbi.nlm.nih.gov/pubmed/2897197 | https://adisinsight.springer.com/drugs/800000037

Tazifylline (also known as LN 2974) is a long-acting histamine H1-receptor antagonist that was studied in clinical trials for the treatment of allergic rhinitis and asthma. In addition, this compound was studied on the itching and scratching of patients with atopic eczema. However, the further development of tazifylline appears to have been discontinued by Roche.

Originator

Approval Year

PubMed

Title	Date	PubMed
Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline.	1986 Apr	2424463
Multiple-dose pharmacokinetics of the new H1-receptor antagonist tazifylline in healthy volunteers.	1989 Jan-Feb	2564283

Sample Use Guides

In Vivo Use Guide

10 mg b.i.d. for 8 days

Route of Administration: Oral

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:37:54 GMT 2023` Edited by `admin` on `Fri Dec 15 16:37:54 GMT 2023`
Record UNII	S05RV1R3LZ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

TAZEPROFEN

Official Name

English

tazeprofen [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C257